Loading clinical trials...
Loading clinical trials...
7T MRI Ferumoxytol-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases
Conditions
Interventions
Feraheme
Gadolinium-based contrast
Locations
2
United States
Richard M. Lucas Center for Imaging (of Stanford University)
Stanford, California, United States
Stanford Hospitals and Clinics
Stanford, California, United States
Start Date
April 1, 2014
Primary Completion Date
September 1, 2018
Completion Date
September 1, 2018
Last Updated
September 10, 2018
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07426991
NCT07376772
Lead Sponsor
Stanford University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions